Stem cell shots take on long COVID: hope for millions?
NCT ID NCT05126563
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether infusions of donor stem cells (HB-adMSCs) could reduce long COVID symptoms like extreme fatigue, brain fog, and headache. About 79 adults with chronic post-COVID syndrome received four IV doses of stem cells or a placebo over 10 weeks. Researchers tracked changes in symptom severity using simple rating scales over 26 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-COVID-19 SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.